Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 4
2020 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Flavonoid-Based Cancer Therapy: An Updated Review.
Hosseinzadeh E, Hassanzadeh A, Marofi F, Alivand MR, Solali S. Hosseinzadeh E, et al. Anticancer Agents Med Chem. 2020;20(12):1398-1414. doi: 10.2174/1871520620666200423071759. Anticancer Agents Med Chem. 2020. PMID: 32324520 Review.
Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1.
Hassanzadeh A, Hosseinzadeh E, Rezapour S, Vahedi G, Haghnavaz N, Marofi F. Hassanzadeh A, et al. Among authors: hosseinzadeh e. Anticancer Agents Med Chem. 2019;19(12):1523-1534. doi: 10.2174/1871520619666190729150442. Anticancer Agents Med Chem. 2019. PMID: 31362681
Effects of guluronic acid, as a new NSAID with immunomodulatory properties on IL-17, RORγt, IL-4 and GATA-3 gene expression in rheumatoid arthritis patients.
Khadem Azarian S, Jafarnezhad-Ansariha F, Nazeri S, Azizi G, Aghazadeh Z, Hosseinzadeh E, Mirshafiey A. Khadem Azarian S, et al. Among authors: hosseinzadeh e. Immunopharmacol Immunotoxicol. 2020 Feb;42(1):22-27. doi: 10.1080/08923973.2019.1702053. Epub 2019 Dec 19. Immunopharmacol Immunotoxicol. 2020. PMID: 31856612 Clinical Trial.